Voyager Therapeutics, Inc. (VYGR)

Voyager Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	112.53	68.8	98.96	117.43	104.44	86.04
Short-Term Investments	232.84	162.07	19.89	15.11	76.7	195.49
Cash & Short-Term Investments	345.36	230.88	118.85	132.54	181.14	281.53
Cash Growth	36.54%	94.26%	-10.33%	-26.83%	-35.66%	80.69%
Accounts Receivable	19.67	83.49	0.26	0.73	8.01	18.5
Other Receivables	-	0.96	0.38	0.02	0.1	0.48
Receivables	19.67	84.46	0.64	0.75	8.11	18.97
Prepaid Expenses	8.42	0.61	0.7	1.36	1.46	0.2
Other Current Assets	-	3.75	4.32	2.05	7.07	3.95
Total Current Assets	373.44	319.68	124.5	136.7	197.77	304.66
Property, Plant & Equipment	49.72	30	33.34	55.38	61.5	46.46
Long-Term Investments	-	-	-	-	-	1.92
Other Long-Term Assets	2.87	1.59	1.52	1.78	2.32	1.72
Total Assets	426.04	351.28	159.36	193.86	261.58	354.76
Accounts Payable	3.16	1.6	2.57	0.57	0.63	4.07
Accrued Expenses	11.44	16.82	7.82	10.95	14.21	21.52
Current Portion of Leases	6.98	3.2	2.83	5.57	4.2	3.19
Current Unearned Revenue	22.63	42.88	59.38	33.89	7.73	47.23
Total Current Liabilities	44.21	64.51	72.59	50.98	26.77	76.01
Long-Term Leases	38.37	17.09	20.29	38.61	43.41	30.98
Long-Term Unearned Revenue	12.15	32.36	6.45	8.21	36.09	147.26
Other Long-Term Liabilities	1	1	1	1	1	1
Total Liabilities	95.73	114.96	100.34	98.8	107.26	255.25
Common Stock	0.06	0.04	0.04	0.04	0.04	0.04
Additional Paid-In Capital	621.99	497.51	452.71	442.26	430.32	412.23
Retained Earnings	-291.7	-261.18	-393.51	-347.1	-275.91	-312.65
Comprehensive Income & Other	-0.03	-0.05	-0.22	-0.14	-0.13	-0.1
Total Common Equity	330.31	236.32	59.02	95.06	154.32	99.51
Shareholders' Equity	330.31	236.32	59.02	95.06	154.32	99.51
Total Liabilities & Equity	426.04	351.28	159.36	193.86	261.58	354.76
Total Debt	45.35	20.29	23.13	44.18	47.61	34.17
Net Cash (Debt)	300.01	210.58	95.72	88.36	133.53	249.29
Net Cash Growth	29.37%	119.99%	8.33%	-33.83%	-46.43%	59.35%
Net Cash Per Share	5.38	4.72	2.50	2.35	3.58	6.94
Filing Date Shares Outstanding	54.63	54.3	43.29	38.11	37.65	37.15
Total Common Shares Outstanding	54.54	44.04	38.61	37.92	37.37	36.87
Working Capital	329.23	255.18	51.91	85.72	171	228.65
Book Value Per Share	6.06	5.37	1.53	2.51	4.13	2.70
Tangible Book Value	330.31	236.32	59.02	95.06	154.32	99.51
Tangible Book Value Per Share	6.06	5.37	1.53	2.51	4.13	2.70
Machinery	-	23.16	22.01	21.91	20.5	15.64
Construction In Progress	-	-	-	-	0.87	2.19
Leasehold Improvements	-	7.11	12.55	15.7	15.47	7.13

Source: S&P Capital IQ. Standard template. Financial Sources.